SCHEMBL24625904

SCHEMBL24625904

CCCCCCCCCC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(N)=O)C(=O)NC(CC(=O)O)C(=O)NC1C(=O)NCC(=O)NC(CCCN)C(=O)NC(CC(=O)O)C(=O)NC(C)C(=O)NC(C(=O)O)CC(=O)NCC(=O)NC(CO)C(=O)NC(C(C)CC(=O)O)C(=O)NC(CC(=O)c2ccccc2N)C(=O)OC1C

nearest known ligand 0.92

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSL P07711 1/20 0.92
DRD1 P21728 1/20 0.92
PTGS1 P23219 1/20 0.92
PDE4A P27815 1/20 0.92
EPHA2 P29317 1/20 0.40
F2 P00734 1/20 0.40
KEAP1 Q14145 2/20 0.38
NECTIN4 Q96NY8 2/20 0.37
F11 P03951 1/20 0.37
SHH Q15465 1/20 0.37
KCNMA1 Q12791 1/20 0.37
KCNMB4 Q86W47 1/20 0.37
ESR1 P03372 1/20 0.37
ESR2 Q92731 1/20 0.37
IL23R Q5VWK5 4/20 0.37
SSTR2 P30874 2/20 0.37
KRAS P01116 1/20 0.37
SSTR1 P30872 1/20 0.37
SSTR4 P31391 1/20 0.37
SSTR3 P32745 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Daptomycin SCHEMBL17253124 0.96 CTSL (1.00) CTSLDRD1PTGS1PDE4AEPHA2
Daptomycin SCHEMBL28103 0.96 CTSL (1.00) CTSLDRD1PTGS1PDE4AEPHA2
Daptomycin SCHEMBL13491700 0.96 CTSL (1.00) CTSLDRD1PTGS1PDE4AEPHA2
Daptomycin SCHEMBL23046993 0.96 CTSL (1.00) CTSLDRD1PTGS1PDE4AEPHA2
Daptomycin SCHEMBL8227262 0.96 CTSL (1.00) CTSLDRD1PTGS1PDE4AEPHA2
Daptomycin SCHEMBL28102 0.96 CTSL (1.00) CTSLDRD1PTGS1PDE4AEPHA2
Daptomycin SCHEMBL17351683 0.96 CTSL (1.00) CTSLDRD1PTGS1PDE4AEPHA2
Daptomycin SCHEMBL8221760 0.96 CTSL (1.00) CTSLDRD1PTGS1PDE4AEPHA2
Daptomycin SCHEMBL21402170 0.96 CTSL (1.00) CTSLDRD1PTGS1PDE4AEPHA2
Daptomycin SCHEMBL2724847 0.96 CTSL (1.00) CTSLDRD1PTGS1PDE4AEPHA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220218784-A1 Daptomycin Aqueous Formulations HIKMA PHARMACEUTICALS USA INC. 2022-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220218784-A1 Daptomycin Aqueous Formulations NRDC, PHOSPHO1, MLST8 CTSL 71/4885DRD1 2534/4885PTGS1 4219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.